Downregulation of NKG2DLs by TGF-beta in human lung cancer cells
Downregulation of NKG2DLs by TGF-β in human lung cancer cells
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q3Scopus Q3
- 저널
- BMC IMMUNOLOGY22(1) · 2021
- 피인용
- Web of Science 24Scopus 26
- FWCI (Scopus)
- 0.73
- JCR IF
- JCR 2020 3.615
- ISSN
- 1471-2172
저자
- 이영신제1저자Department of Biochemistry, Pusan National University School of Medicine, Yangsan, 50162, South Korea
- 최호정Department of Biochemistry, Pusan National University School of Medicine, Yangsan, 50162, South Korea
- 조해령PNU BK21 Plus Biomedical Science Education Center, Pusan National University School of Medicine, Yangsan, 50612, South Korea
- Son, Woo-ChangDepartment of Research Center, Dongnam Institute of Radiological and Medical Sciences, Gijang, Busan, 46033, South Korea
- Park, You-SooDepartment of Research Center, Dongnam Institute of Radiological and Medical Sciences, Gijang, Busan, 46033, South Korea
- 강치덕Department of Biochemistry, Pusan National University School of Medicine, Yangsan, 50162, South Korea
- 배재호교신저자PNU BK21 Plus Biomedical Science Education Center, Pusan National University School of Medicine, Yangsan, 50612, South Korea
초록
BackgroundTransforming growth factor beta (TGF-beta) is a typical immuno-inhibitory cytokine and highly secreted by lung cancer cells. It was supposed that its immunosuppressive effects to NK cell might be related with the altered expression of activating and inhibitory molecules in lung cancer cells. In this study, we examined the expression of NKG2DLs, PD-L1 and PD-L2 in lung cancer cells after treatment of TGF-beta and a TGF-beta inhibitor, Galunisertib (LY2157299).ResultsTGF-beta reduced the level of surface proteins of five NKG2DLs without altered transcription levels in lung cancer cells. Galunisertib reversed the effect of TGF-beta on the expression of NKG2DLs. Since MMP inhibitors, MMPi III and MMP2 inhibitor I, restored the reduced expression of NKG2DLs after treatment of TGF-beta, it was thought that TGF-beta induced the expression of MMP2 which facilitated the shedding of the NKG2DLs in cancer cells. However, the expression of PD-L1, L2 were not changed by treatment with TGF-beta or Galunisertib.ConclusionsTherefore, inhibition of TGF-beta might reverse the immunosuppressive status on immune cells and restore NK cell mediated anticancer immune responses by upregulation of NKG2DLs in cancer cells.
키워드
NKG2D ligandsTransforming growth factor betaMatrix metalloproteinaseGROWTH-FACTOR-BETANATURAL-KILLER-CELLSURFACE EXPRESSIONIMMUNE-RESPONSENK CELLST-CELLSLIGANDSIMMUNOSUPPRESSIONIMMUNOTHERAPYGLIOBLASTOMA
식별자
- Scopus EID
- 2-s2.0-85109915892
- WoS UID
- 000674511700001



로그인
연구물 목록으로